. 2016 Dec 18;31(1):51–54. doi: 10.1016/j.sjopt.2016.12.003

Table 1.

Reported cases of endophthalmitis following intravitreal dexamethasone implant injection.

Authors, Year published	Age (years), Sex, Indication	Time of presentation	Clinical features	Management	Organism isolated	Final outcome
Marchino T, et al., 2013³	74, F, CRVO	2 days	Pain, redness, DOV, PL+, hypopyon, grade 4 vitreous opacity	IVAB, followed by PPV + implant removal (“Vitreotome tip”)	Alloiococcus otitidis	CF 30 cm, macular fibrosis
Arıkan Yorgun M, et al., 2014⁴	58, M, BRVO	2 days	Painful DOV, HM, hypopyon, no red reflex	PPV + implant removal (forceps) + IVAB, repeat PPV after 2 days	Negative	3/60
Esen E, et al., 2015 Case 1⁵	68, F, DME	3 days	Pain, redness, DOV, HM, 4 + AC cells, poor red reflex	IVAB, repeated after 3 days	Negative	6/60
Esen E, et al., 2015 Case 2⁵	63, F, BRVO	3 days	Pain, redness, DOV, HM, 4 + AC cells, vitreous inflammation	IVAB, repeated after 3 days	Negative	6/36
Current case	70, M, DME	12 days	DOV, no pain, CF close to face, no hypopyon, grade 3 vitreous opacity, fragmented implant	IVAB, followed by PPV + implant removal (forceps/cutter)	Coagulase negative Staphylococcus	6/18

M - male, F - female, CRVO - central retinal vein occlusion, BRVO - branch retinal vein occlusion, DME - diabetic macular edema, DOV - diminution of vision, PL - perception of light, HM - hand motions, CF - counting fingers, AC - anterior chamber, IVAB - intravitreal antibiotics, PPV - pars plana vitrectomy.